These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22047825)

  • 1. Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study.
    Brender JD; Werler MM; Kelley KE; Vuong AM; Shinde MU; Zheng Q; Huber JC; Sharkey JR; Griesenbeck JS; Romitti PA; Langlois PH; Suarez L; Canfield MA;
    Am J Epidemiol; 2011 Dec; 174(11):1286-95. PubMed ID: 22047825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Periconceptional Use of Nitrosatable Drugs on the Risk of Neural Tube Defects.
    Benedum CM; Yazdy MM; Mitchell AA; Werler MM
    Am J Epidemiol; 2015 Oct; 182(8):675-84. PubMed ID: 26424074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects.
    Brender JD; Olive JM; Felkner M; Suarez L; Marckwardt W; Hendricks KA
    Epidemiology; 2004 May; 15(3):330-6. PubMed ID: 15097014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations.
    Brender JD; Werler MM; Shinde MU; Vuong AM; Kelley KE; Huber JC; Sharkey JR; Griesenbeck JS; Romitti PA; Malik S; Suarez L; Langlois PH; Canfield MA;
    Birth Defects Res A Clin Mol Teratol; 2012 Sep; 94(9):701-13. PubMed ID: 22903972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects.
    Shinde MU; Vuong AM; Brender JD; Werler MM; Kelley KE; Huber JC; Sharkey JR; Zheng Q; Suarez L; Langlois PH; Canfield MA; Romitti PA; Malik S;
    Birth Defects Res A Clin Mol Teratol; 2013 Aug; 97(8):515-31. PubMed ID: 23716465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age Births.
    Vuong AM; Shinde MU; Brender JD; Shipp EM; Huber JC; Zheng Q; McDonald TJ; Sharkey JR; Hoyt AT; Werler MM; Kelley KE; Langlois PH; Canfield MA;
    Paediatr Perinat Epidemiol; 2015 Jan; 29(1):60-71. PubMed ID: 25492517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal Exposure to Nitrosatable Drugs, Dietary Intake of Nitrites, and Preterm Birth.
    Vuong AM; Shinde MU; Brender JD; Shipp EM; Huber JC; Sharkey JR; McDonald TJ; Werler MM; Kelley KE; Griesenbeck JS; Langlois PH; Canfield MA;
    Am J Epidemiol; 2016 Apr; 183(7):634-42. PubMed ID: 26953287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy.
    Brender JD; Kelley KE; Werler MM; Langlois PH; Suarez L; Canfield MA;
    Birth Defects Res A Clin Mol Teratol; 2011 Apr; 91(4):258-64. PubMed ID: 21472845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours.
    McKean-Cowdin R; Pogoda JM; Lijinsky W; Holly EA; Mueller BA; Preston-Martin S
    Int J Epidemiol; 2003 Apr; 32(2):211-7. PubMed ID: 12714539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to nitrosatable drugs and timing of puberty in sons and daughters: A nationwide cohort study.
    Clemmensen PJ; Brix N; Schullehner J; Ernst A; Harrits Lunddorf LL; Bjerregaard AA; Halldorsson TI; Olsen SF; Hansen B; Stayner LT; Kolstad HA; Sigsgaard T; Ramlau-Hansen CH
    Int J Hyg Environ Health; 2023 Sep; 254():114271. PubMed ID: 37820420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study.
    Huber JC; Brender JD; Zheng Q; Sharkey JR; Vuong AM; Shinde MU; Griesenbeck JS; Suarez L; Langlois PH; Canfield MA; Romitti PA; Weyer PJ;
    Nutr J; 2013 Mar; 12():34. PubMed ID: 23514444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
    Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
    J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrosatable drug exposure during pregnancy and risk of stillbirth.
    Thomsen AML; Liew Z; Riis AH; Stayner LT; Ramlau-Hansen CH; Sigsgaard T; Olsen J
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1204-1210. PubMed ID: 31348585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal nitrate intake from drinking water and selected birth defects in offspring of participants in the national birth defects prevention study.
    Brender JD; Weyer PJ; Romitti PA; Mohanty BP; Shinde MU; Vuong AM; Sharkey JR; Dwivedi D; Horel SA; Kantamneni J; Huber JC; Zheng Q; Werler MM; Kelley KE; Griesenbeck JS; Zhan FB; Langlois PH; Suarez L; Canfield MA;
    Environ Health Perspect; 2013 Sep; 121(9):1083-9. PubMed ID: 23771435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal nitrosatable prescription drug intake, drinking water nitrate, and the risk of stillbirth: a register- and population-based cohort of Danish pregnancies, 1997-2017.
    Thomsen AML; Ramlau-Hansen CH; Schullehner J; Ebdrup NH; Liew Z; Coffman V; Stayner L; Hansen B; Olsen J
    Environ Health; 2021 Nov; 20(1):118. PubMed ID: 34781958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.
    Mosley BS; Cleves MA; Siega-Riz AM; Shaw GM; Canfield MA; Waller DK; Werler MM; Hobbs CA;
    Am J Epidemiol; 2009 Jan; 169(1):9-17. PubMed ID: 18953063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to nitrosatable drugs during pregnancy and childhood cancer: A matched case-control study in Denmark, 1996-2016.
    Sirirungreung A; Hansen J; He D; Huang X; Ritz B; Heck JE
    Pharmacoepidemiol Drug Saf; 2023 Apr; 32(4):496-505. PubMed ID: 36300575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-affected pregnancies?
    Shaw GM; Velie EM; Schaffer DM
    Teratology; 1997 Nov; 56(5):295-9. PubMed ID: 9451752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and ethnicity and preconception folic acid supplement use among pregnant women in Georgia, PRAMS 2009 to 2011.
    Mukhtar A; Kramer MR; Oakley GP; Kancherla V
    Birth Defects Res; 2017 Jan; 109(1):38-48. PubMed ID: 27905191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate.
    Suarez L; Hendricks KA; Cooper SP; Sweeney AM; Hardy RJ; Larsen RD
    Am J Epidemiol; 2000 Dec; 152(11):1017-23. PubMed ID: 11117610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.